Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about ESALY

Recent news which mentions ESALY

< Previous 1 2 3 4 5 Next >

Why Biogen, Lilly, and Prothena Stocks Are Skyrocketing Today

September 28, 2022

Why Acumen Pharmaceuticals Stock Is Soaring Today

September 28, 2022

Why Is Cassava Sciences (SAVA) Stock Heating Up Today?

September 28, 2022

Why Is Biogen (BIIB) Stock Up 40% Today?

September 28, 2022

Is iPhone Demand Really Slowing Down?, Lyft Freezes Hiring, Biogen's New Drug Slows Alzheimer's Progression: Top Financial Media Stories Wednesday, Sept. 28

September 28, 2022

What In The World Is Going On With Biogen (BIIB) Shares?

September 28, 2022

Why Cassava Sciences Shares Are Soaring Higher

September 28, 2022

Why Biogen Stock Is Up 40% Today

September 28, 2022

2 Sympathy Plays To Watch For In The Wake Of Biogen's Positive Alzheimer's Drug Data

September 28, 2022

US Stock Futures Down Ahead Of Fed Speakers, Economic Data

September 28, 2022

Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression

September 28, 2022

Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock

September 28, 2022

Merck's Keytruda Combo Trial Fails To Meet Primary Goal In Liver Cancer

September 12, 2022

Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate

August 25, 2022

Here's What Could Make This Beaten-Down Stock a Buy

August 19, 2022

Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial

August 03, 2022

Merck's Two Keytruda Combo Cancer Trials Miss Primary Goal

August 03, 2022

Merck's Oncology Business Will Help It Crush the Bear Market

July 07, 2022

Is This Biotech Stock a Bad News Buy?

July 06, 2022

The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate

July 06, 2022

2 Safe Stocks to Buy in a Bear Market

May 21, 2022

The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves

May 10, 2022

Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug

May 10, 2022

1 Reason to Buy Biogen Now, and 1 Reason to Wait

May 05, 2022

Lilly’s experimental weight-loss drug may be a ‘multibillion-dollar opportunity’

April 29, 2022

Is This Biotech Stock Worth the Trouble?

April 23, 2022

What This Regulatory Approval Could Mean for Merck

April 05, 2022

The Daily Biotech Pulse: SELLA In-licenses Oncology Asset, Merck's Pneumococcal Vaccine Review Extended, Arc Biopharma COVID Drug Flunks Mid-Stage Study

April 01, 2022

Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab

March 22, 2022

FDA Approves Second Indication For Merck's Keytruda In Endometrial Cancer

March 22, 2022

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.